These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis. Alves GF; Stoppa I; Aimaretti E; Monge C; Mastrocola R; Porchietto E; Einaudi G; Collotta D; Bertocchi I; Boggio E; Gigliotti CL; Clemente N; Aragno M; Fernandes D; Cifani C; Thiemermann C; Dianzani C; Dianzani U; Collino M Front Immunol; 2022; 13():992614. PubMed ID: 36119089 [TBL] [Abstract][Full Text] [Related]
7. Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis. Raineri D; Abreu H; Vilardo B; Kustrimovic N; Venegoni C; Cappellano G; Chiocchetti A Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473756 [TBL] [Abstract][Full Text] [Related]
8. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus. Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933 [TBL] [Abstract][Full Text] [Related]
9. Involvement of inducible costimulator ligand (ICOSL) expression in thyroid tissue in hyperthyroidism of Graves' disease patients. Wang F; Yan T; Chen L; Chen X; Liu T; Shen S; Li T; Gao L; Wang T; Sun J; Liu C; Wu H; Zhang X; Chen L J Clin Immunol; 2012 Dec; 32(6):1253-61. PubMed ID: 22706735 [TBL] [Abstract][Full Text] [Related]
10. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis. Hasegawa M; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K Rheumatology (Oxford); 2013 Feb; 52(2):242-51. PubMed ID: 23024058 [TBL] [Abstract][Full Text] [Related]
12. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells. Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S Front Immunol; 2018; 9():2227. PubMed ID: 30319662 [TBL] [Abstract][Full Text] [Related]
13. Reverse signaling using an inducible costimulator to enhance immunogenic function of dendritic cells. Tang G; Qin Q; Zhang P; Wang G; Liu M; Ding Q; Qin Y; Shen Q Cell Mol Life Sci; 2009 Sep; 66(18):3067-80. PubMed ID: 19603141 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS-ICOSL interaction. Fan X; Xu ZB; Li CL; Zhang HY; Peng YQ; He BX; Liu XQ; Chen DH; Chen D; Akdis CA; Fu QL Stem Cells; 2021 Jul; 39(7):975-987. PubMed ID: 33662168 [TBL] [Abstract][Full Text] [Related]
15. ICOS-mediated costimulation on Th2 differentiation is achieved by the enhancement of IL-4 receptor-mediated signaling. Watanabe M; Watanabe S; Hara Y; Harada Y; Kubo M; Tanabe K; Toma H; Abe R J Immunol; 2005 Feb; 174(4):1989-96. PubMed ID: 15699127 [TBL] [Abstract][Full Text] [Related]
16. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis. Provera A; Ramavath NN; Gadipudi LL; Gigliotti CL; Boggio E; Vecchio C; Stoppa I; Rolla R; Boldorini R; Pirisi M; Smirne C; Albano E; Dianzani U; Sutti S Front Immunol; 2023; 14():1290391. PubMed ID: 38077334 [TBL] [Abstract][Full Text] [Related]
17. B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice. Hamel KM; Cao Y; Olalekan SA; Finnegan A Arthritis Rheumatol; 2014 Jan; 66(1):60-7. PubMed ID: 24449576 [TBL] [Abstract][Full Text] [Related]
18. B7h is required for T cell activation, differentiation, and effector function. Nurieva RI; Mai XM; Forbush K; Bevan MJ; Dong C Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14163-8. PubMed ID: 14615582 [TBL] [Abstract][Full Text] [Related]
19. T helper 22 cells from Han Chinese patients with atopic dermatitis exhibit high expression of inducible T-cell costimulator. Jiao Q; Qian Q; Liu C; Luo Y; Fang F; Wang M; Ji J; Qian H; Zhang X; Maurer M Br J Dermatol; 2020 Mar; 182(3):648-657. PubMed ID: 31090221 [TBL] [Abstract][Full Text] [Related]
20. CTLA4-Ig-Based Bifunctional Costimulation Inhibitor Blocks CD28 and ICOS Signaling to Prevent T Cell Priming and Effector Function. Goenka R; Xu Z; Samayoa J; Banach D; Beam C; Bose S; Dooner G; Forsyth CM; Lu X; Medina L; Sadhukhan R; Sielaff B; Sousa S; Tao Q; Touw D; Wu F; Kingsbury GA; Akamatsu Y J Immunol; 2021 Mar; 206(5):1102-1113. PubMed ID: 33495237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]